MARA Holdings
MARA
MicroStrategy
MSTR
Tesla
TSLA
Coinbase
COIN
Amazon
AMZN
US Stock MarketDetailed Quotes
MNMD Mind Medicine
- 7.1800
- -0.3600-4.77%
Close Jan 3 16:00 ET
- 7.2196
- +0.0396+0.55%
Post 19:59 ET
526.52MMarket Cap-4.20P/E (TTM)
7.8800High7.0700Low2.07MVolume7.6500Open7.5400Pre Close15.04MTurnover3.87%Turnover RatioLossP/E (Static)73.33MShares12.220052wk High2.01P/B383.44MFloat Cap3.490052wk Low--Dividend TTM53.40MShs Float86.5500Historical High--Div YieldTTM10.74%Amplitude2.1200Historical Low7.2800Avg Price1Lot Size
Mind Medicine News
Insider Sale: Chief Executive Officer of $MNMD (MNMD) Sells 19,106 Shares
MindMed Stock Skyrockets 94% Year to Date: What's Driving It?
Mind Medicine Price Target Announced at $20.00/Share by Chardan Capital
Mind Medicine Initiated at Buy by Chardan Capital
Mind Medicine to Join Nasdaq Biotechnology Index
Express News | MindMed To Be Added To The Nasdaq Biotechnology Index, Effective At Market Open On December 23, 2024
Mind Medicine Analyst Ratings
Oppenheimer Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $20
Mind Medicine (MNMD) Receives a Buy From Oppenheimer
MindMed Doses First Patient in Phase 3 Trial of LSD Trial for Anxiety
Express News | Mind Medicine (MindMed) Inc - Panorama Study to Initiate in U.S. and Europe in First Half of 2025
Express News | MindMed Announces First Patient Dosed in Phase 3 Voyage Study of Mm120 in Generalized Anxiety Disorder (Gad)
MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress
Mind Medicine Gets UK's Innovation Passport Designation for Investigational Anxiety Disorder Treatment
Express News | Mind Medicine: Awarded Innovation Passport Designation by UK Ilap Steering Group for Mm120 Odt for Generalized Anxiety Disorder
Express News | MindMed Appoints Javier Muniz, M.d., as Vice President of Research and Development Strategy
MindMed Announces New Employee Inducement Grants
RBC Capital Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $21
RBC Capital Remains a Buy on Mind Medicine (MNMD)
Mind Medicine Appoints Gregg Pratt Chief Regulatory, Quality Assurance Officer
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.